FindTrial
Sign In

A multicenter trial to evaluate the safety and effectiveness of Elekta Unity MR-guided radiotherapy system

A multicenter trial to evaluate the safety and effectiveness of Elekta Unity MR-guided radiotherapy system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038338
Enrollment
Unknown
Registered
2020-09-18
Start date
2019-02-18
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

1. Spine & extemities
2. Head & neck (including CNS)
3. Pelvis
4. Throax & abdomen:Radiation Therapy

Sponsors

Shandong Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with malignant tumors who have agreed to receive radiotherapy; 2. Those who did not have any contraindications for radiotherapy and magnetic resonance imaging; 3. Those who meet the requirements of age and health status.

Exclusion criteria

Exclusion criteria: 1. Any patients who are contraindicated by radiotherapy or magnetic resonance imaging; 2. Patients with a risk of life-threatening complications associated with radiotherapy > 1%; 3. Patients who need concurrent chemotherapy.

Design outcomes

Primary

MeasureTime frame
Device related Grade III above toxicities;—

Secondary

MeasureTime frame
Use to study the effectiveness of elekta unity;—

Countries

China

Contacts

Public ContactYan Chen

Elekta Instrument (Shanghai) Ltd.

yan.chen@elekta.com+86 10-56692885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026